Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Global supply chains have seen significant disruption from the spread of COVID-19. For crop protection, it has interrupted production along the entire crop input value chain — from raw materials to manufacturing to packaging to distribution to transportation.
Since the COVID-19 virus has spread through the United States, you’ve no doubt found your local stores sold out of essential items, such as toilet paper, hand sanitizer, and many food products.
The coronavirus pandemic has resulted in a very dynamic situation. We’ve had to adjust our plans accordingly. Shelter-in-place orders in individual states have disrupted the supply chain sooner than anticipated. Consequently, BMW Plant Spartanburg will close for a two-week period beginning Sunday, March 29, through Sunday, April 12. We will continue to monitor the ongoing situation very closely and adjust our plans as circumstances dictate.
Chinese exports plummeted 17.2 percent in dollar terms in the first two months of the year as the Asian giant grappled with the effects of the spread of Covid-19. The coronavirus outbreak has shed light on the risks of companies relying on China as a sole source of manufactured goods, as factory closures and transportation restrictions disrupted global supply chains in sectors ranging from pharmaceuticals to electronics to auto production.
The COVID-19 pandemic has brought medical supply chains into the spotlight. There has been a national shortage of testing kits, and at least one drug is already unavailable because of the outbreak, though it hasn’t been publicly named.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine